0.75
-5.06%
Close of 9 Nov 2026, in CAD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Cresco Labs
Its shares trade on Canadian Securities Exchange under the ticker CL.CN. It has been listed since 3 December 2018. In the fiscal year to 31 December 2025, it reported revenue of $655.8m and a net loss of $135.4m. At that date it held total assets of $1.20bn and shareholders' equity of $340.4m.
Cresco Labs Inc. engages in the business of cultivating medical grade cannabis, manufacturing medical products derived from cannabis cultivation, and distributing such products to medical or adult use consumers. The company is headquartered in Chicago, Illinois. The company went IPO on 2018-12-03. The firm manufactures a suite of cannabis extracts and vape products. The firm is a processor and retailer of cannabis products with operations in six states, including Illinois, Ohio, Pennsylvania, Nevada, California and Arizona. The company distributes its cannabis products to dispensaries.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 3 Dec 2018
- Employees
- 1,400
- Website
- crescolabs.com ↗
Leadership
Pay as last reported
- Mr. Thomas ManningNon-Executive Chairman of the Board, since 2019$135,000
- Mr. Gregory ButlerPresident$806,980
- Mr. Charles BachtellChief Executive Officer, Director, since 2018$1.4m
- Ms. Sharon SchulerChief Financial Officer$141,672
- Ms. Angie DemchenkoChief People Officer
- Mr. Zach MarburgerChief Information Officer
- Mr. John SchetzGeneral Counsel
- Mr. Jason ErkesChief Communications Officer
- Mr. Gerald CorcoranIndependent Director$89,375
- Mr. Marc LustigIndependent Director, since 2020$68,342
- Mr. Randy PodolskyIndependent Director$83,750
- Ms. Michele RobertsIndependent Director$128,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 18
- Environment
- 19
- Social
- 26
- Governance
- 10
- Carbon reduction policy
- No
- Human rights policy
- No
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Cresco Labs Inc has a strong presence in the cannabis industry, with significant market share and a well-established brand.
- The company has a diverse product portfolio that includes a wide range of cannabis strains and derivatives, catering to different consumer preferences.
- Cresco Labs Inc boasts a robust distribution network, allowing them to reach customers in various markets effectively.
Weaknesses
- As a cannabis company, Cresco Labs Inc faces legal and regulatory challenges in certain jurisdictions, which could limit its expansion opportunities.
- The company heavily relies on the cannabis market, making it vulnerable to changes in regulations or consumer demand.
- Cresco Labs Inc may face difficulties in building strong brand loyalty due to the highly competitive nature of the cannabis industry.
Opportunities
- With the increasing legalization and acceptance of cannabis, Cresco Labs Inc can capitalize on new markets and expand its operations.
- The company has the opportunity to further diversify its product offerings by exploring new cannabis derivatives or entering related industries, such as CBD products or infused beverages.
- Growing consumer interest in natural and alternative remedies provides an opportunity for Cresco Labs Inc to promote the health benefits of cannabis products.
Threats
- The cannabis industry faces stringent regulations and uncertainty, which poses a threat to Cresco Labs Inc's operations, particularly in regions where legalization is not widespread.
- Intense competition within the cannabis market could put pressure on Cresco Labs Inc's pricing and profitability.
- External factors such as economic downturns or changes in consumer preferences could impact the demand for cannabis products and affect the company's financial performance.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.